Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Orgiazzi

Showing results (131-140 of 157) with videos related to

Pageof 16
Sort By:
Clinical and Experimental Immunology|July 15, 1999
T cell response pattern to glutamic acid decarboxylase 65 (GAD65) peptides of newly diagnosed type 1 diabetic patients sharing susceptible HLA haplotypesF Rharbaoui, A Mayer, C Granier, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1986
T lymphocyte subsets at various stages of hyperthyroid Graves' disease: effect of carbimazole treatment and relationship with thyroid-stimulating antibody levels or HLA statusA M Madec, H Allannic, N Genetet, et al.
The Journal of Clinical Endocrinology and Metabolism|November 7, 2003
Kinetics of thyrotropin-stimulating hormone (TSH) and thyroid-stimulating antibody binding and action on the TSH receptor in intact TSH receptor-expressing CHO cellsJ Van Sande, M J Costa, C Massart, et al.
European Journal of Endocrinology|July 5, 2007
Contrasting cellular and humoral autoimmunity associated with latent autoimmune diabetes in adultsA Mayer, N Fabien, M C Gutowski, et al.
Acta Endocrinologica|August 1, 1982
Familial hyperthyroidism without evidence of autoimmunityJ S Thomas, J Leclere, P Hartemann, et al.
Clinical and Experimental Immunology|December 18, 2003
Modulation of antigen presentation by autoreactive B cell clones specific for GAD65 from a type I diabetic patientJ P Banga, J K Moore, N Duhindan, et al.
European Journal of Endocrinology|April 29, 2006
Is there a need to redefine the upper normal limit of TSH?G Brabant, P Beck-Peccoz, B Jarzab, et al.
Clinical Endocrinology|September 1, 1984
Thyroid stimulating antibodies: an aid to the strategy of treatment of Graves' disease?A M Madec, M C Laurent, Y Lorcy, et al.
Diabetologia|June 1, 1992
Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individualsC H Thivolet, M Tappaz, A Durand, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1984
Paradoxical response of thyrotropin to L-dopa and presence of dopaminergic receptors in a thyrotropin-secreting pituitary adenomaP Chanson, J Orgiazzi, P J Derome, et al.
Pageof 16

Showing results (131-140 of 157) with videos related to

Sort By:
Pageof 16
Clinical and Experimental Immunology|July 15, 1999
T cell response pattern to glutamic acid decarboxylase 65 (GAD65) peptides of newly diagnosed type 1 diabetic patients sharing susceptible HLA haplotypesF Rharbaoui, A Mayer, C Granier, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1986
T lymphocyte subsets at various stages of hyperthyroid Graves' disease: effect of carbimazole treatment and relationship with thyroid-stimulating antibody levels or HLA statusA M Madec, H Allannic, N Genetet, et al.
The Journal of Clinical Endocrinology and Metabolism|November 7, 2003
Kinetics of thyrotropin-stimulating hormone (TSH) and thyroid-stimulating antibody binding and action on the TSH receptor in intact TSH receptor-expressing CHO cellsJ Van Sande, M J Costa, C Massart, et al.
European Journal of Endocrinology|July 5, 2007
Contrasting cellular and humoral autoimmunity associated with latent autoimmune diabetes in adultsA Mayer, N Fabien, M C Gutowski, et al.
Acta Endocrinologica|August 1, 1982
Familial hyperthyroidism without evidence of autoimmunityJ S Thomas, J Leclere, P Hartemann, et al.
Clinical and Experimental Immunology|December 18, 2003
Modulation of antigen presentation by autoreactive B cell clones specific for GAD65 from a type I diabetic patientJ P Banga, J K Moore, N Duhindan, et al.
European Journal of Endocrinology|April 29, 2006
Is there a need to redefine the upper normal limit of TSH?G Brabant, P Beck-Peccoz, B Jarzab, et al.
Clinical Endocrinology|September 1, 1984
Thyroid stimulating antibodies: an aid to the strategy of treatment of Graves' disease?A M Madec, M C Laurent, Y Lorcy, et al.
Diabetologia|June 1, 1992
Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individualsC H Thivolet, M Tappaz, A Durand, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1984
Paradoxical response of thyrotropin to L-dopa and presence of dopaminergic receptors in a thyrotropin-secreting pituitary adenomaP Chanson, J Orgiazzi, P J Derome, et al.
Pageof 16